Regn-Cov2 reduces deaths and shortens hospitalisation for these patients, even when given at late stages of infection
Long-time University of Kentucky researcher resigns the day before Board was to vote on whether to revoke his tenure for research misconduct
New body will foster evidence-informed decision-making and awareness programmes for the public
Good news for industry and future drug approvals, but physicians doubt it will be effective for most patients
Three others injured at facility in Guizhou after accidental release during unloading
Blaze killed 18 workers, mainly women, who were trapped inside SVS Aqua Technologies plant
Discoverer of the Negishi coupling, who did synthetic organic chemistry research at Purdue for four decades, has passed away
Amine solvent in use at 13 other plants could be deployed at Yorkshire plant by 2027
Stopping bacteria from producing hydrogen sulfide in response to drugs could help overcome antimicrobial resistance
Reaction driven by long-lived radicals experiences fewer side reactions than photopolymerisation under light irradiation
In a discovery that raises more question than it answers, researchers have found zero-oxidation-state iron and copper deposits inside amyloid plaques
Helen Pain replaces Robert Parker at the helm of the society, with immediate effect
Tributes paid to NMR spectroscopy pioneer credited with laying the foundations for the development of MRI
Autumn spending review will now be crucial in deciding whether UK hits R&D spending targets for 2024–25
Chemist contacted by suspicious Wikipedia editor finds that large sections were lifted from online encyclopaedia
Risk takers wanted to lead UK’s agency modelled on the US’s Darpa
$1.7bn deal will be funded by selling rights to royalties on existing drugs
Decision means J&J must pay $2.1 billion previously awarded to 22 women who say talc caused their ovarian cancer
Pemex will take full control of Deer Park refinery, as Mexico’s president moves to gain energy independence
Synchrotron generated at least £1.8 million in benefits for the country
Sale of digital data related to cancer immunotherapy and Crispr will be used to finance research
Directive finalised at the end of Trump’s presidency would have hindered use of non-public data in policymaking
It’s been almost 10 years since the world was warned of a post-antibiotic apocalypse. Katrina Megget takes a look at the initiatives trying to support antimicrobial R&D
Whitening agent ’no longer considered safe’ as a food additive based on results from thousands of recent studies
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
Hundreds of fake research manuscripts from paper mills have flooded biochemical and biomedical journals in recent years. But how do you stop large-scale fraud barely anything is known about?
